Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.640
-0.050 (-1.36%)
At close: Sep 12, 2025, 4:00 PM EDT
3.650
+0.010 (0.28%)
After-hours: Sep 12, 2025, 7:59 PM EDT

Altimmune Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
321513604808363417
Upgrade
Market Cap Growth
-33.43%-15.16%-25.23%122.62%-12.91%1369.44%
Upgrade
Enterprise Value
154375464608165212
Upgrade
Last Close Price
3.647.2111.2516.459.1611.28
Upgrade
PS Ratio
16062.8225640.431418.90-11888.9082.3550.95
Upgrade
PB Ratio
1.924.153.114.361.821.85
Upgrade
P/TBV Ratio
1.994.153.114.681.951.96
Upgrade
EV/Sales Ratio
7700.0218760.081090.28-37.3925.91
Upgrade
Debt / Equity Ratio
0.100.010.000.010.010.01
Upgrade
Asset Turnover
000.00-0.020.06
Upgrade
Quick Ratio
19.9512.9016.6910.9910.7318.99
Upgrade
Current Ratio
20.4413.1117.2611.3111.1719.16
Upgrade
Return on Equity (ROE)
-55.91%-59.86%-46.63%-44.07%-45.69%-36.14%
Upgrade
Return on Assets (ROA)
-32.43%-36.85%-25.00%-25.73%-22.86%-16.10%
Upgrade
Return on Capital (ROIC)
-35.57%-40.31%-27.38%-28.31%-24.76%-17.52%
Upgrade
Earnings Yield
-27.31%-18.54%-14.63%-10.48%-26.74%-11.76%
Upgrade
FCF Yield
-25.39%-15.57%-12.55%-7.76%-24.88%-8.28%
Upgrade
Buyback Yield / Dilution
-17.90%-33.35%-13.47%-13.67%-61.03%-95.33%
Upgrade
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q